IntroductionThe regulation of lymphocyte survival and differentiation is of central importance to immunity and the homeostasis of the immune system. BAFF 1 (also known as BLYS, TALL-1, THANK, ZTNF4, TNFSF13B) is an important TNF-related molecule with critical effects on B cells (1) (2) (3) (4) (5) (6) . Produced predominantly by myeloid cells, BAFF is a B cell survival factor and a costimulator of B cell proliferation and antibody secretion (7;8) . The human BAFF homotrimer crystal structure has been determined by three different groups and is typical of the TNF group (9) (10) (11) . The basic "jellyroll β sandwich" of the TNF monomer fold is retained in BAFF. The monomer-monomer interactions are mediated by conserved hydrophobic residues, forming three grooves on the sides of the trimer that can interact with receptors.
TNF family polypeptides are type II transmembrane proteins biologically active when presented in the membrane-bound position or in the soluble phase following release from the membrane by specific proteolysis in the membrane-proximal, "stalk" region (8;12-15) . In the case of TNF, membrane release requires the cis-acting metalloproteinase TACE (16) . BAFF has been found both on cell surfaces and in solution, but the proteases responsible for its release have not been identified. However, the basic cleavage site in the stalk region of BAFF is consistent with a furin-like convertase (8) .
BAFF binds to three different receptors, BAFF-R, TACI, and BCMA. All of these receptors are expressed on B cells, although their expression levels change with maturation (17) . In addition, TACI is also expressed on activated T cells (18) . Mice functionally deficient in BAFF-R (19) are severely depleted in follicular and marginal zone B cells (20) (21) (22) . BAFF-deficient mice have a very similar phenotype (23) , suggesting that the BAFF-R has a non-redundant function in maintaining B cell survival. In contrast, the TACI knockout is defective in responses to T cell independent antigens, not in B cell survival; on the contrary, B cell numbers are increased 2-fold Human BAFF was amplified using 5'-ACTGTGCTAGCTCAGGGTCCAGAAGAAACA and 5'-TCTCGGATCCTAATAGCTACAGACATGGTGTAAGTA.
The amplification products were electrophoresed on 4% agarose gels and then gel purified and cloned into pBluescript for DNA sequencing (ABI). The sequences for mouse and human ∆BAFF cDNA have been deposited in Genbank (AY290823 and AY302751 respectively). Full-length mouse BAFF cDNA containing an upstream myc tag on the N-terminus, was cloned into the bicistronic retroviral vector pMXI-IRES-EGFP (34) . The full-length mouse ∆BAFF cDNA with an N-terminal FLAG tag was cloned into pMX1-IRES-TAC, where the EGFP cDNA from pMXI-IRES-EGFP, was replaced with the cDNA encoding human CD25 as a downstream marker gene.
Expression of BAFF Isoforms
S17 cells, a bone marrow stromal cell line, were infected by retroviruses encoding the mouse BAFF isoforms. Briefly, retroviruses were generated by the transfection of the constructs into Phoenix cells by CaPO 4 precipitation, and the supernatant harvested 48 hours post transfection.
The supernatants containing the retroviruses and 1% (v/v) dotap (Roche), were then incubated with monolayers of S17 cells for 2 hours while being centrifuged at 2000g at 30°C. The supernatant was replaced with fresh IMDM growth medium, and positively infected cells were sorted by flow cytometry, based on their expression of either EGFP, Human CD25, or both. In some cases, full length transmembrane BAFF isoforms were expressed transiently in 293T cells using Lipofectamine 2000 (Invitrogen) according to manufacturers instructions.
Recombinant sBAFF
Recombinant mouse soluble BAFF (sBAFF) and soluble delta BAFF (s∆BAFF) with either Nterminal poly-histidine or FLAG epitope tags, were subcloned into pCEP.Pu (pCEP4 containing a puromycin resistance cassette) or pCMV-Script (Stratagene). The pCep.Pu constructs were transfected into 293 EBNA cells (Invitrogen) and stable transfectants were selected for with Geneticin (0.25mg/ml) and Puromycin (0.5µg/ml). Recombinant soluble BAFF proteins were purified from culture supernatant using anti-FLAG agarose chromatography according to the manufacturer's instructions (Sigma).
Biochemical Analysis of BAFF Isoforms
Culture supernatants from stably transfected 293 EBNA cells were used as a source of sBAFF and s∆BAFF. Recombinant BAFF was immunoprecipitated from culture supernatant using either anti-HIS or anti-FLAG agarose beads. The beads were washed with PBS, and in some cases boiled in the presence of 0.5% SDS and 1% β-mercaptoethanol then incubated with PNGase buffer and 1%NP-40 and to half the samples, 1000U PNGase F (New England Biolabs) was added. After incubation at 37°C for 1 hour, samples were incubated with sample buffer (reducing and non-reducing) at 56°C for 10 mins and then boiled 5 minutes. Iodoacetamide was added and the samples were electrophoresed on 15% acrylamide SDS-PAGE. Non-reducing samples were treated the same, but were not initially denatured with SDS and β-mercaptoethanol. 
BAFF Biological Assay
B cells were purified from spleen and lymph nodes from B10.D2 mice using CD43 or B220 MACS beads and columns (Miltenyi Biotec). CD43-B cells were cultured at 1x10 6 cells/ml with 10µg/ml Goat F(ab) 2 anti mouse IgM (Southern Biotechnology) and plated on monolayers of various dilutions of irradiated S17 cells, and incubated for 72-96 hours. Cell viability was assessed by forward and side scatter analysis performed on a FACScan (Becton Dickinson). In some cases, B220+ B cells were incubated with titrations of recombinant purified soluble BAFF forms in medium containing 25µg/ml polymyxin B and 10µg/ml anti IgM as described above.
RESULTS

Identification of BAFF Transcripts in Mouse and Human Myeloid Cells
In the course of reverse transcription and polymerase chain reaction (RT-PCR) cloning of BAFF from cDNA generated from the mouse myeloid cell line WEHI-3, we observed that half of the clones had a slightly smaller than expected size. Sequencing analysis revealed that the smaller transcript, herein known as ∆BAFF, was identical to the published BAFF sequence, but lacked 57bp encoding the predicted A to A1 strands and intervening loop ( Figure 1A ) (9) . The ∆BAFF Primary mouse bone marrow derived macrophages also expressed the alternatively spliced isoform (Fig 2A, lane 15 ). The ∆BAFF isoform was expressed in the human cell lines tested, although it was only a minor species. A larger transcript (BAFF-ϕ) was identified in the human cell lines, but sequencing revealed this transcript to be non-functional, due to incomplete splicing of intronic sequence leading to premature stop codons. The smaller transcripts identified in HL-60, J774, Pu5-1.8 and B10.D2 macrophages were gel purified and sequenced, revealing that they were identical to ∆BAFF that was identified initially from WEHI-3 cDNA. These results indicate that ∆BAFF is expressed along with BAFF in many mouse and human myeloid cells and cell lines.
BAFF has an Additional Glycosylation Site and Forms Disulfide-Bonded Multimers
The biochemical properties of ∆BAFF were analyzed by generating peptide-tagged and truncated soluble BAFF and ∆BAFF (sBAFF and s∆BAFF, respectively) in 293 EBNA cells ( Figure 3A ).
Under reducing conditions, the s∆BAFF form (lane 5) had a higher apparent molecular weight than sBAFF (lane 2). Incubation with Peptide N-Glycosidase F enzyme (PNGase) revealed the slowed mobility of s∆BAFF was the result of additional N-linked glycosylation at the newly generated site. The addition of PNGase and reducing reagents led to the predicted mobility of s∆BAFF (lane 4) relative to sBAFF (lane1). The electrophoretic mobility difference was more easily observed when both forms were co-expressed by 293 EBNA cells (lanes 7-9).
Interestingly, under non-reducing conditions some multimers of sBAFF were observed (lane 3), but s∆BAFF appeared mostly as high molecular weight multimers (lanes 6 and 9), implying a role for disulphide bonds in multimer stabilization. We conclude that ∆BAFF mRNA encodes a protein with similarities to BAFF, including immunoreactivity and the ability to covalently homomultimerize.
Unlike BAFF, BAFF is not Efficiently Shed from Expressing Cells
Full length transmembrane anchored forms of BAFF and ∆BAFF cDNAs were transiently transfected into 293T cells to compare these isoforms for membrane expression and shedding into the extracellular medium. BAFF and ∆BAFF were detected in cell lysates, although ∆ BAFF was expressed to a lesser extent ( Figure 3B left panel). BAFF that had been cleaved was detected in the culture supernatant ( Figure 3B right panel), whereas ∆BAFF was not detected.
Interestingly, the amount of BAFF cleaved in cells co-expressing both forms of BAFF was less than BAFF alone, implying a role for ∆BAFF in inhibiting BAFF secretion.
To further assess the biochemical properties of the transmembrane forms of BAFF and ∆BAFF in a system with stable expression, pMX1 retroviral constructs were generated encoding either fulllength BAFF with an N-terminal myc tag, or full-length ∆BAFF with an N-terminal FLAG tag ( Figure 4A ). The BAFF constructs were linked to either EGFP or Human CD25 via an internal ribosomal entry site (IRES) sequence, which allowed detection of the positively infected cells using flow cytometry. A mouse bone marrow stromal cell line, S17, was infected with the various retroviruses, and infected cells were sorted based on expression of EGFP, Human CD25, or both ( Figure 4B ). Three stably-expressing S17 cell lines were generated, S17 BAFF-myc, S17 ∆BAFF-FLAG, and S17 BAFF-myc + ∆BAFF-FLAG, which expressed either full length BAFF, full length ∆BAFF, or co-expressed both, respectively. Similar expression levels of the BAFF isoforms were detected in the cell lysates of the transduced S17 cells ( Figure 4C lanes 2-4) BAFF and BAFF form Heteromultimers. Because the inability of ∆BAFF to be released from cells might have important biological consequences, the mechanism of its retention was explored further. As the predicted proteolytic cleavage site was retained in ∆BAFF, its inability to be shed into the supernatant implied that it was either not expressed on the cell surface, or that the loss of residues around the A strand and additional glycosylation may have inhibited cleavage. Surface iodination and immunoprecipitation from lysates of S17 cells that expressed the various BAFF forms revealed that ∆BAFF, when expressed alone, was present on the cell surface ( Figure 4D lane 3). Cell surface expression was also observed when both BAFF and ∆BAFF were coexpressed (lane 4). This result indicated that ∆BAFF multimers could be expressed on the cell surface and suggested that ∆BAFF could have a function independent of full length BAFF.
Because some members of the TNF superfamily can form heterotrimers, the possibility that ∆BAFF associates with BAFF was tested in a coprecipitation assay using epitope tagged versions of these molecules. Immunoprecipitations were performed from lysates of S17 cells RANKL similarly leads to ablation of cognate receptor binding (42) (43) (44) (45) . It is interesting to note that in the case of human APRIL, a TNF family member closely related to BAFF, a transcript (TRDL-1β) lacking the equivalent exon encoding the A-A1 strand has also been described, although not functionally characterized (46) . As is the case for mouse ∆BAFF, TRDL-1β also creates an additional potential N-linked glycosylation site at the new exon:exon junction, and in light of the data presented herein, we would predict altered function for this APRIL isoform. As heterotrimers between APRIL and BAFF have been described and are in higher amounts in humans with systemic autoimmune disease, it is interesting to postulate the role ∆BAFF and the APRIL isoform TRDL-1β may have on tightly regulating the potency of BAFF/APRIL functions.
Alternate splicing of the region critical for receptor binding may be an efficient way to regulate how much functional BAFF, or APRIL, is on the surface or is available for proteolytic cleavage.
It is not excluded that, in addition to its ability to limit BAFF function, ∆BAFF may have independent bioactivity. Importantly, surface iodination/immunoprecipitation studies revealed that mouse ∆BAFF can be found on the cell surface ( Figure 4D ). This finding is apparently in contrast to the unpublished data mentioned by Mackay et al regarding the human ∆BAFF form (6), a discrepancy that may be explained by species or cell type differences. The surface expression of ∆BAFF indicates that, although it does not bind to two of the known BAFF receptors, ∆BAFF may have a unique receptor specificity or function which is yet to be determined. (C) The level of BAFF and ∆BAFF expression by S17 cells alone, or after infection with BAFFmyc, ∆BAFF-FLAG, or both retroviruses, was determined by western blotting of total cell lysate and concentrated culture supernatant using anti-BAFF polyclonal antibody.
(D) Surface expression of ∆BAFF. S17 cells alone, or S17 infected with retroviral constructs were cell surface iodinated, then cell lysates were incubated with anti-FLAG agarose beads, and immunoprecipitated material was analyzed by SDS-PAGE and auto-radiography. (A) Cell lysates from either S17 alone, or S17 expressing full-length BAFF (myc tag) or ∆BAFF (FLAG tag), or both, were incubated with anti-FLAG agarose and immunoprecipitated material was analyzed by western blotting with either anti-FLAG or anti-myc specific antibodies.
(B) Supernatants from 293 EBNA cells expressing soluble BAFF with a histidine tag, soluble ∆BAFF with a FLAG tag, or both forms, were incubated with anti-FLAG agarose beads, washed and analyzed by western blotting with anti-FLAG and anti-HIS specific antibodies Figure 6 . ∆BAFF does not bind to the receptor, TACI.
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